Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study R Guerreiro, OA Ross, C Kun-Rodrigues, DG Hernandez, T Orme, ... The Lancet Neurology 17 (1), 64-74, 2018 | 237 | 2018 |
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 215 | 2021 |
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk Y Deming, F Filipello, F Cignarella, C Cantoni, S Hsu, R Mikesell, Z Li, ... Science translational medicine 11 (505), eaau2291, 2019 | 208 | 2019 |
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease M Ewers, N Franzmeier, M Suárez-Calvet, E Morenas-Rodriguez, ... Science translational medicine 11 (507), eaav6221, 2019 | 206 | 2019 |
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology M Suárez-Calvet, E Morenas-Rodríguez, G Kleinberger, K Schlepckow, ... Molecular neurodegeneration 14, 1-14, 2019 | 192 | 2019 |
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ... Neurology 85 (7), 626-633, 2015 | 169 | 2015 |
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ... Annals of neurology 76 (2), 223-230, 2014 | 136 | 2014 |
Cortical microstructural changes along the Alzheimer's disease continuum V Montal, E Vilaplana, D Alcolea, J Pegueroles, O Pasternak, ... Alzheimer's & Dementia 14 (3), 340-351, 2018 | 129 | 2018 |
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker? A Abdelhak, T Hottenrott, E Morenas-Rodríguez, M Suárez-Calvet, ... Frontiers in neurology 10, 280, 2019 | 108 | 2019 |
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 104 | 2019 |
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls F Sampedro, E Vilaplana, MJ De Leon, D Alcolea, J Pegueroles, V Montal, ... Oncotarget 6 (29), 26663, 2015 | 104 | 2015 |
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease D Alcolea, E Vilaplana, J Pegueroles, V Montal, P Sánchez-Juan, ... Neurobiology of aging 36 (6), 2018-2023, 2015 | 97 | 2015 |
Lesions causing hallucinations localize to one common brain network NY Kim, J Hsu, D Talmasov, J Joutsa, L Soussand, O Wu, NS Rost, ... Molecular psychiatry 26 (4), 1299-1309, 2021 | 90 | 2021 |
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 86 | 2022 |
Validación de la versión española del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia JA Matias-Guiu, RF de Bobadilla, G Escudero, J Pérez-Pérez, A Cortés, ... Neurologia 30 (9), 545-551, 2015 | 86 | 2015 |
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation M Ewers, G Biechele, M Suárez‐Calvet, C Sacher, T Blume, ... EMBO molecular medicine 12 (9), e12308, 2020 | 85 | 2020 |
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM 2, neurodegeneration and cognitive decline M Suárez‐Calvet, A Capell, MÁ Araque Caballero, E Morenas‐Rodríguez, ... EMBO molecular medicine 10 (12), e9712, 2018 | 81 | 2018 |
Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms G Naasan, SM Shdo, EM Rodriguez, S Spina, L Grinberg, L Lopez, ... Brain 144 (3), 999-1012, 2021 | 77 | 2021 |
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain D Alcolea, P Martínez-Lage, A Izagirre, M Clerigué, M Carmona-Iragui, ... Journal of Alzheimer's Disease 39 (4), 719-726, 2014 | 75 | 2014 |
Regional overlap of pathologies in Lewy body disorders M Colom-Cadena, O Grau-Rivera, L Planellas, C Cerquera, E Morenas, ... Journal of Neuropatholgy & Experimental Neurology 76 (3), 216-224, 2017 | 74 | 2017 |